San Diego State University is responsible for ensuring that recombinant DNA research or experiments involving biological materials or potentially hazardous materials are conducted in compliance with the National Institutional Health (NIH) Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules (NIH Guidelines) and the CDC Biosafety in Microbiological and Biomedical Laboratories (BMBL) guidelines to promote safe and responsible practices. On behalf of SDSU, the Institutional Biosafety Committee (IBC) reviews research for this purpose, and holds a registration with the NIH Office of Science Policy. The IBC is a committee of the University Research Council appointed by the Vice President for Research. Graduate and Research Affairs' Division of Research Affairs provides administrative support to the IBC. The IBC membership is determined based on federal guidance and includes a biosafety officer, an animal expert, scientists, and private citizens.
Principal Investigators using biohazardous materials or conducting experiments involving recombinant DNA in their laboratories must obtain approval from the IBC. To initiate this process, the investigator must complete a Biological Use Authorization (BUA) Form.